These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36707416)

  • 1. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example.
    Meng Q; Ding B; Ma P; Lin J
    Small Methods; 2023 May; 7(5):e2201406. PubMed ID: 36707416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
    Inoue H; Tani K
    Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
    Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
    Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of programmed cell death by Brd4.
    Hu J; Pan D; Li G; Chen K; Hu X
    Cell Death Dis; 2022 Dec; 13(12):1059. PubMed ID: 36539410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine-induced programmed cell death enhances tumor immunotherapy.
    Lu J; Tai Z; Wu J; Li L; Zhang T; Liu J; Zhu Q; Chen Z
    J Adv Res; 2024 Aug; 62():199-217. PubMed ID: 37743016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells.
    He Q; Qu M; Xu C; Shi W; Hussain M; Jin G; Zhu H; Zeng LH; Wu X
    Life Sci; 2022 Feb; 290():120257. PubMed ID: 34952041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death in tumor immunity: mechanistic insights and clinical implications.
    Wang M; Yu F; Zhang Y; Li P
    Front Immunol; 2023; 14():1309635. PubMed ID: 38283351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Immunogenic Cell Death by Apoptosis/Ferroptosis Hybrid Pathway Potentiates PD-L1 Blockade Cancer Immunotherapy.
    Jeong SD; Jung BK; Lee D; Ha J; Chang HG; Lee J; Lee S; Yun CO; Kim YC
    ACS Biomater Sci Eng; 2022 Dec; 8(12):5188-5198. PubMed ID: 36449494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
    Liu Y; Chang R; Xing R; Yan X
    Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the interplay between m6A modification and programmed cell death in cancer.
    Chen J; Ye M; Bai J; Hu C; Lu F; Gu D; Yu P; Tang Q
    Int J Biol Sci; 2023; 19(6):1748-1763. PubMed ID: 37063421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment.
    Yang LJ; Han T; Liu RN; Shi SM; Luan SY; Meng SN
    Biomed Pharmacother; 2024 Aug; 177():117099. PubMed ID: 38981240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
    Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
    Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
    Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic Cell Death Induction by Ionizing Radiation.
    Zhu M; Yang M; Zhang J; Yin Y; Fan X; Zhang Y; Qin S; Zhang H; Yu F
    Front Immunol; 2021; 12():705361. PubMed ID: 34489957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating the complexities of cell death: Insights into accidental and programmed cell death.
    Lotfi MS; Rassouli FB
    Tissue Cell; 2024 Dec; 91():102586. PubMed ID: 39426124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.